Yuan Peng
6PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 01, 2025
Impact of baseline glucocorticoid use on the efficacy of immunotherapy combined with intracranial radiotherapy in NSCLC patients with brain metastases.Jin Xiong, Wenhao Shi, Yusheng Huang
|Aug 06, 2024
Innate immune dynamics in the context of multisite EGFR mutations in lung adenocarcinoma.Yuan Peng, Chuan Zeng, Rongxin Liao
|Sep 11, 2023
Toxicity spectrum and risk factors for chemo-immunotherapy in locally advanced or metastatic lung cancer.Jinjin Li, Wenhao Shi, Jin Xiong
|Sep 24, 2022
BDNF is a prognostic biomarker involved in immune infiltration of lung adenocarcinoma and is associated with brain metastasis.Qian Yu, Yitian Wang, Guangming Yi
|Jan 05, 2022
Toxic epidermal necrolysis during camrelizumab treatment for esophageal squamous cell carcinoma.Yuan Peng, Qian Yu, Xiaoyue Zhang
|Aug 03, 2021
Successful management of lung adenocarcinoma with ALK/EGFR co-alterations and PD-L1 over-expression by bevacizumab combined with chemotherapy.Hengqiu He, Wendi Yang, Yusheng Huang
Pageof 1
